semaglutide cardiac protection Cardiovascular outcomes of and tirzepatide for patients with type 2 diabetes in clinical practice GLP-1 medications can protect the

Supply varies due to global shortages and import schedules

5 This was an exciting study that was published recently in the New England Journal of Medicine and it was the first time we had compared tirzepatide with a GLP-1 agonist (semaglutide) in people with T2D. Figure 1 shows the design of the SURPASS-2 study 1,4 *Patients with T2D who had inadequate glycemic control on stable doses of metformin alone to receive once-weekly SC tirzepatide 5 mg, 10 mg, 15 mg, or once-weekly SC semaglutide 1 mg (1:1:1:1 ratio), all in combination with metformin 1500 mg/day

Drinking most of your water earlier in the day and tapering intake toward evening reduces nighttime bathroom visits

Tirzepatide and semaglutide shared similar rates for nausea, diarrhea, abdominal pain, and dyspepsia, but semaglutide had higher rates of vomiting, constipation, and GERD

There is no minimum or maximum amount of desired weight loss that "qualifies" an individual for the medication, but rather it depends on health history and goals

Henry works with compounding pharmacies to deliver drugs to your door, so you dont have to go to a local pharmacy to pick anything up